{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:34:38Z","timestamp":1790289278412,"version":"4.1.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05845-z","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T12:49:28Z","timestamp":1743857368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence, molecular mechanisms and diagnostic approaches to pulmonary arterial hypertension in connective tissue diseases"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3438-0764","authenticated-orcid":false,"given":"Bogna","family":"Grygiel-G\u00f3rniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6788-6067","authenticated-orcid":false,"given":"Mateusz","family":"Lucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7738-6023","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"Daroszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8248-2247","authenticated-orcid":false,"given":"Ewa","family":"Lucka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"5845_CR1","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1378\/chest.10-0260","volume":"138","author":"L Chung","year":"2010","unstructured":"Chung L, Liu J, Parsons L et al (2010) Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest 138:1383\u20131394","journal-title":"Chest"},{"issue":"25 Suppl","key":"5845_CR2","doi-asserted-by":"publisher","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","volume":"62","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Bogaard HJ, Condliffe R et al (2013) Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D42-50","journal-title":"J Am Coll Cardiol"},{"key":"5845_CR3","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","volume":"53","author":"G Simonneau","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53:1801913","journal-title":"Eur Respir J"},{"key":"5845_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1378\/chest.10-2327","volume":"140","author":"R Zhang","year":"2011","unstructured":"Zhang R, Dai LZ, Xie WP et al (2011) Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era. Chest 140:301\u2013309","journal-title":"Chest"},{"key":"5845_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.610257","volume":"7","author":"R Amarnani","year":"2021","unstructured":"Amarnani R, Yeoh SA, Denneny EK, Wincup C (2021) Lupus and the lungs: the assessment and management of pulmonary manifestations of systemic lupus erythematosus. Front Med (Lausanne) 7:610257","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"5845_CR6","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.3390\/ijms24065085","volume":"24","author":"K Parperis","year":"2023","unstructured":"Parperis K, Velidakis N, Khattab E, Gkougkoudi E, Kadoglou NPE (2023) Systemic lupus erythematosus and pulmonary hypertension. Int J Mol Sci 24(6):5085","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5845_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/14017431.2016.1185532","volume":"50","author":"G Radegran","year":"2016","unstructured":"Radegran G, Kjellstrom B, Ekmehag B et al (2016) Characteristics and survival of adult Swedish PAH and CTEPH patients 2000\u20132014. Scand Cardiovasc J 50(4):243\u2013250","journal-title":"Scand Cardiovasc J"},{"issue":"8","key":"5845_CR8","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/art.40512","volume":"70","author":"EY Yen","year":"2018","unstructured":"Yen EY, Singh RR (2018) Brief report: lupus\u2014an unrecognized leading cause of death in young females: a population-based study using nationwide death certificates, 2000\u20132015. Arthritis Rheumatol 70(8):1251\u20131255","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"5845_CR9","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/1756-185X.12645","volume":"20","author":"KY Kang","year":"2017","unstructured":"Kang KY, Jeon CH, Choi SJ et al (2017) Survival and prognostic factors in patients with connective tissue disease-associated pulmonary hypertension diagnosed by echocardiography: results from a Korean nationwide registry. Int J Rheum Dis 20(9):1227\u20131236","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"5845_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","volume":"179","author":"R Condliffe","year":"2009","unstructured":"Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, Das C, Elliot CA, Johnson M, DeSoyza J, Torpy C, Goldsmith K, Hodgkins D, Hughes RJ, Pepke-Zaba J, Coghlan JG (2009) Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179(2):151\u2013157","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"5845_CR11","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1093\/rheumatology\/kead055","volume":"62","author":"B Chaigne","year":"2023","unstructured":"Chaigne B, Chevalier K, Boucly A, Agard C, Baudet A, Bourdin A, Chabanne C, Cottin V, Fesler P, Goupil F, Jego P, Launay D, L\u00e9vesque H, Maurac A, Mohamed S, Tromeur C, Rottat L, Sitbon O, Humbert M, Mouthon L (2023) In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study. Rheumatology (Oxford) 62(10):3261\u20133267","journal-title":"Rheumatology (Oxford)"},{"key":"5845_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/854941","volume":"2012","author":"A Dhala","year":"2012","unstructured":"Dhala A (2012) Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction. Clin Dev Immunol 2012:854941","journal-title":"Clin Dev Immunol"},{"issue":"12","key":"5845_CR13","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/rheumatology\/kep203","volume":"48","author":"A Prabu","year":"2009","unstructured":"Prabu A, Patel K, Yee CS, Nightingale P, Situnayake RD, Thickett DR, Townend JN, Gordon C (2009) Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) 48(12):1506\u20131511","journal-title":"Rheumatology (Oxford)"},{"key":"5845_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2019-000356","volume":"6","author":"M Mizus","year":"2019","unstructured":"Mizus M, Li J, Goldman D, Petri MA (2019) Autoantibody clustering of lupus-associated pulmonary hypertension. Lupus Sci Med 6:e000356","journal-title":"Lupus Sci Med"},{"key":"5845_CR15","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/rheumatology\/kes140","volume":"51","author":"Y Shirai","year":"2012","unstructured":"Shirai Y, Yasuoka H, Okano Y, Takeuchi T, Satoh T, Kuwana M (2012) Clinical characteristics and survival of Japanese patients with connective tissue disease and pulmonary arterial hypertension: a single-centre cohort. Rheumatology (Oxford) 51:1846\u20131854","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"5845_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Gali\u00e8","year":"2015","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2015) 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 46(4):903\u2013975","journal-title":"Eur Respir J"},{"issue":"6","key":"5845_CR17","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","volume":"201","author":"D Khanna","year":"2020","unstructured":"Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J (2020) Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am J Respir Crit Care Med 201(6):650\u2013660","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5845_CR18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jaad.2021.10.065","volume":"87","author":"R Jerjen","year":"2022","unstructured":"Jerjen R, Nikpour M, Krieg T, Denton CP, Saracino AM (2022) Systemic sclerosis in adults: part I\u2014clinical features and pathogenesis. J Am Acad Dermatol 87(5):937\u2013954","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"5845_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.semarthrit.2010.08.004","volume":"41","author":"S Chatterjee","year":"2011","unstructured":"Chatterjee S (2011) Pulmonary hypertension in systemic sclerosis. Semin Arthritis Rheum 41(1):19\u201337","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"5845_CR20","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s10067-024-06961-0","volume":"43","author":"A Sar\u0131","year":"2024","unstructured":"Sar\u0131 A, Sat\u0131\u015f H, Ayan G, K\u00fc\u00e7\u00fck\u015fahin O, Kalyoncu U, Fidanc\u0131 AA, Ayval\u0131 MO, Ata N, \u00dclg\u00fc MM, Birinci \u015e, Akdo\u011fan A (2024) Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era-results from a nationwide study. Clin Rheumatol 43(6):1919\u20131925. https:\/\/doi.org\/10.1007\/s10067-024-06961-0. (PMID: 38676757)","journal-title":"Clin Rheumatol"},{"issue":"16","key":"5845_CR21","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"VV McLaughlin","year":"2009","unstructured":"McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR et al (2009) ACCF\/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on expert consensus documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the pulmonary hypertension association. Circulation 119(16):2250\u20132294","journal-title":"Circulation"},{"issue":"11","key":"5845_CR22","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3899\/jrheum.100245","volume":"37","author":"J Avouac","year":"2010","unstructured":"Avouac J, Air\u00f2 P, Meune C, Beretta L, Dieude P, Caramaschi P, Tiev K, Cappelli S, Diot E, Vacca A, Cracowski JL, Sibilia J, Kahan A, Matucci-Cerinic M, Allanore Y (2010) Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 37(11):2290\u20132298","journal-title":"J Rheumatol"},{"issue":"1","key":"5845_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102713","volume":"20","author":"M Rubio-Rivas","year":"2021","unstructured":"Rubio-Rivas M, Homs NA, Cuartero D, Corbella X (2021) The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: systematic review and meta-analysis. Autoimmun Rev 20(1):102713","journal-title":"Autoimmun Rev"},{"issue":"4","key":"5845_CR24","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/rheumatology\/kead360","volume":"63","author":"O Distler","year":"2024","unstructured":"Distler O, Ofner C, Huscher D, Jordan S, Ulrich S, St\u00e4hler G et al (2024) Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis. Rheumatology (Oxford) 63(4):1139\u20131146","journal-title":"Rheumatology (Oxford)"},{"key":"5845_CR25","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1002\/art.21433","volume":"52","author":"E Hachulla","year":"2005","unstructured":"Hachulla E, Gressin V, Guillevin L et al (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 52:3792\u20133800","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5845_CR26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s11926-012-0302-2","volume":"15","author":"A Yaqub","year":"2013","unstructured":"Yaqub A, Chung L (2013) Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis. Curr Rheumatol Rep 15(1):302","journal-title":"Curr Rheumatol Rep"},{"issue":"1 Suppl","key":"5845_CR27","doi-asserted-by":"publisher","first-page":"78S","DOI":"10.1378\/chest.126.1_suppl.78S","volume":"126","author":"VV McLaughlin","year":"2004","unstructured":"McLaughlin VV, Presberg KW, Doyle RL, Abman SH, McCrory DC, Fortin T, Ahearn G, American College of Chest Physicians (2004) Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):78S-92S","journal-title":"Chest"},{"issue":"9","key":"5845_CR28","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1002\/art.22069","volume":"54","author":"MR Fisher","year":"2006","unstructured":"Fisher MR, Mathai SC, Champion HC, Girgis RE, Housten-Harris T, Hummers L, Krishnan JA, Wigley F, Hassoun PM (2006) Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 54(9):3043\u20133050","journal-title":"Arthritis Rheum"},{"key":"5845_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-0039-1685537","volume":"40","author":"JR Hannah","year":"2019","unstructured":"Hannah JR, D\u2019Cruz DP (2019) Pulmonary complications of systemic lupus erythematosus. Semin Respir Crit Care Med 40:227\u2013234","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"5845_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/0961203307080629","volume":"16","author":"A Kasparian","year":"2007","unstructured":"Kasparian A, Floros A, Gialafos E, Kanakis M, Tassiopoulos S, Kafasi N, Vaiopoulos G (2007) Raynaud\u2019s phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus 16(7):505\u2013508","journal-title":"Lupus"},{"key":"5845_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1573397113666170704102444","volume":"13","author":"K Tselios","year":"2017","unstructured":"Tselios K, Urowitz MB (2017) Cardiovascular and pulmonary manifestations of systemic lupus erythematosus. Curr Rheumatol Rev 13:206\u2013218","journal-title":"Curr Rheumatol Rev"},{"issue":"4","key":"5845_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1183\/09031936.00182813","volume":"44","author":"YJ Hao","year":"2014","unstructured":"Hao YJ, Jiang X, Zhou W et al (2014) Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients. Eur Respir J 44(4):963\u2013972","journal-title":"Eur Respir J"},{"issue":"10","key":"5845_CR33","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/0961203314527366","volume":"23","author":"M Li","year":"2014","unstructured":"Li M, Wang Q, Lhao J et al (2014) Chinese SLE Treatment and Research group (CSTAR) registry: II\u2014prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus. Lupus 23(10):1085\u20131091","journal-title":"Lupus"},{"issue":"5","key":"5845_CR34","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00296-012-2525-y","volume":"33","author":"YK Xia","year":"2013","unstructured":"Xia YK, Tu SH, Hu YA et al (2013) Pulmonary hypertension in systemic lupus erythematosus: a systematic review and analysis of 642 cases in Chinese population. Rheumatol Int 33(5):1211\u20131217","journal-title":"Rheumatol Int"},{"key":"5845_CR35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/1756-185X.12262","volume":"18","author":"KJ Kim","year":"2015","unstructured":"Kim KJ, Baek IW, Park YJ, Yoon CH, Kim WU, Cho CS (2015) High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension. Int J Rheum Dis 18:524\u2013532","journal-title":"Int J Rheum Dis"},{"key":"5845_CR36","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1002\/art.21131","volume":"52","author":"FM Wigley","year":"2005","unstructured":"Wigley FM, Lima JAC, Mayes M, McLain D, Chapin JL, Ward-Able C (2005) The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis Rheum 52:2125\u20132132","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"5845_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000783","volume":"4","author":"B Chaigne","year":"2018","unstructured":"Chaigne B, Scir\u00e8 CA, Talarico R, Alexander T, Amoura Z, Avcin T, Beretta L, Doria A, Guffroy A, Guimar\u00e3es V, Hachulla \u00c9, Krieg T, Launay D, Lepri G, Moinzadeh P, M\u00fcller-Ladner U, Rednic S, Rodrigues A, Tas SW, van Vollenhoven RF, Vieira A, Bombardieri S, Fonseca JE, Galetti I, Schneider M, Smith V, Cutolo M, Mosca M, Fischer-Betz R (2018) Mixed connective tissue disease: state of the art on clinical practice guidelines. RMD Open 4(Suppl 1):e000783","journal-title":"RMD Open"},{"issue":"5","key":"5845_CR38","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1111\/j.1756-185X.2012.01815.x","volume":"15","author":"CH Jeon","year":"2012","unstructured":"Jeon CH, Chai JY, Seo YI, Jun JB, Koh EM, Lee SK, Pulmonary hypertension study group of Korean College of Rheumatology (2012) Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry. Int J Rheum Dis 15(5):e80\u2013e89","journal-title":"Int J Rheum Dis"},{"issue":"13","key":"5845_CR39","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1177\/0961203312456751","volume":"21","author":"P Szodoray","year":"2012","unstructured":"Szodoray P, Hajas A, Kardos L, Dezso B, Soos G, Zold E, Vegh J, Csipo I, Nakken B, Zeher M, Szegedi G, Bodolay E (2012) Distinct phenotypes in mixed connective tissue disease: subgroups and survival. Lupus 21(13):1412\u20131422","journal-title":"Lupus"},{"issue":"7","key":"5845_CR40","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/rheumatology\/kes430","volume":"52","author":"R Gunnarsson","year":"2013","unstructured":"Gunnarsson R, Andreassen AK, Molberg \u00d8, Lexberg \u00c5S, Time K, Dhainaut AS, Bertelsen LT, Palm \u00d8, Irgens K, Becker-Merok A, Nordeide JL, Johnsen V, Pedersen S, Pr\u00f8ven A, Garabet LS, Garen T, Aal\u00f8kken TM, Gilboe IM, Gran JT (2013) Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature. Rheumatology (Oxford) 52(7):1208\u20131213","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"5845_CR41","first-page":"2301","volume":"41","author":"AB Hassan","year":"2023","unstructured":"Hassan AB, Hozayen RF, Mustafa ZS, Lundberg IE, Jahrami HA (2023) The prevalence of pulmonary arterial hypertension in patients with mixed connective tissue disease: a systematic review and meta-analysis. Clin Exp Rheumatol 41(11):2301\u20132311","journal-title":"Clin Exp Rheumatol"},{"key":"5845_CR42","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3899\/jrheum.121272","volume":"40","author":"A Hajas","year":"2013","unstructured":"Hajas A, Szodoray P, Nakken B, Gaal J, Zold E, Laczik R et al (2013) Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol 40:1134\u20131142","journal-title":"J Rheumatol"},{"issue":"12","key":"5845_CR43","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1002\/art.38172","volume":"65","author":"D Khanna","year":"2013","unstructured":"Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst DE, Hachulla E, Humbert M, Langleben D, Mathai SC, Saggar R, Visovatti S, Altorok N, Townsend W, FitzGerald J, McLaughlin VV, Foundation S, Association PH (2013) Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum 65(12):3194\u20133201","journal-title":"Arthritis Rheum"},{"issue":"10","key":"5845_CR44","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3390\/diagnostics11101931","volume":"11","author":"M Szturmowicz","year":"2021","unstructured":"Szturmowicz M, Franczuk M, J\u0119drych ME, Wyrostkiewicz D, Oniszh K, Darocha S, Kasperowicz K, Kurzyna M (2021) Dominating cause of pulmonary hypertension may change over time-diagnostic and therapeutic considerations in a patient with pulmonary hypertension due to rheumatoid arthritis with lung involvement. Diagnostics (Basel) 11(10):1931","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"5845_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijcard.2006.01.013","volume":"115","author":"N Shariff","year":"2007","unstructured":"Shariff N, Kumar A, Narang R, Malhotra A, Mukhopadhyaya S, Sharma SK (2007) A study of pulmonary arterial hypertension in patients with rheumatoid arthritis. Int J Cardiol 115(1):75\u201376","journal-title":"Int J Cardiol"},{"issue":"3","key":"5845_CR46","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/BOR.0000000000000787","volume":"33","author":"GC McDermott","year":"2021","unstructured":"McDermott GC, Doyle TJ, Sparks JA (2021) Interstitial lung disease throughout the rheumatoid arthritis disease course. Curr Opin Rheumatol 33(3):284\u2013291","journal-title":"Curr Opin Rheumatol"},{"key":"5845_CR47","first-page":"164","volume":"20","author":"E Panagiotidou","year":"2017","unstructured":"Panagiotidou E, Sourla E, Kotoulas SX, Akritidou S, Bikos V, Bagalas V, Stanopoulos I, Pitsiou G (2017) Rheumatoid arthritis associated pulmonary hypertension: clinical challenges reflecting the diversity of pathophysiology. Respir Med Case Rep 20:164\u2013167","journal-title":"Respir Med Case Rep"},{"issue":"3","key":"5845_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/resp.12464","volume":"20","author":"S Sadeghi","year":"2015","unstructured":"Sadeghi S, Granton JT, Akhavan P, Pasarikovski CR, Roos AM, Thenganatt J, Moric J, Johnson SR (2015) Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension. Respirology 20(3):48","journal-title":"Respirology"},{"issue":"1","key":"5845_CR49","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/jcm9010173","volume":"9","author":"G Kope\u0107","year":"2020","unstructured":"Kope\u0107 G, Kurzyna M, Mroczek E, Chrzanowski \u0141, Mularek-Kubzdela T, Skoczylas I et al (2020) Characterization of patients with pulmonary arterial hypertension: data from the Polish Registry of Pulmonary Hypertension (BNP-PL). J Clin Med 9(1):173","journal-title":"J Clin Med"},{"issue":"1","key":"5845_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/medicina60010038","volume":"60","author":"M Rus","year":"2023","unstructured":"Rus M, Ardelean AI, Judea Pusta C, Crisan S, Marian P, Pobirci LO, Huplea V, Osiceanu AS, Osiceanu GA, Andronie-Cioara FL, Guler MI (2023) Prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis. Medicina (Kaunas) 60(1):38","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"5845_CR51","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/cells10061488","volume":"10","author":"I Hernandez-Gonzalez","year":"2021","unstructured":"Hernandez-Gonzalez I, Tenorio-Castano J, Ochoa-Parra N, Gallego N, P\u00e9rez-Olivares C, Lago-Docampo M, Palomino Doza J, Valverde D, Lapunzina P, Escribano-Subias P (2021) Novel genetic and molecular pathways in pulmonary arterial hypertension associated with connective tissue disease. Cells 10(6):1488","journal-title":"Cells"},{"key":"5845_CR52","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ijcard.2017.01.097","volume":"236","author":"J Zhao","year":"2017","unstructured":"Zhao J, Wang Q, Liu Y, Tian Z, Guo X, Wang H, Lai J, Huang C, Yang X, Li M, Zeng X (2017) Clinical characteristics and survival of pulmonary arterial hypertension associated with three major connective tissue diseases: a cohort study in China. Int J Cardiol 236:432\u2013437","journal-title":"Int J Cardiol"},{"issue":"5","key":"5845_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197297","volume":"13","author":"T Sato","year":"2018","unstructured":"Sato T, Hatano M, Iwasaki Y, Maki H, Saito A, Minatsuki S, Inaba T, Amiya E, Fujio K, Watanabe M, Yamamoto K, Komuro I (2018) Prevalence of primary Sj\u00f6gren\u2019s syndrome in patients undergoing evaluation for pulmonary arterial hypertension. PLoS ONE 13(5):e01","journal-title":"PLoS ONE"},{"issue":"21","key":"5845_CR54","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.3390\/jcm10215115","volume":"10","author":"R Goulabchand","year":"2021","unstructured":"Goulabchand R, Roubille C, Montani D, Fesler P, Bourdin A, Malafaye N, Morel J, Arnaud E, Lattuca B, Barateau L, Guilpain P, Mura T (2021) Cardiovascular events, sleep apnoea, and pulmonary hypertension in primary Sj\u00f6gren\u2019s syndrome: data from the French health insurance database. J Clin Med 10(21):5115","journal-title":"J Clin Med"},{"issue":"39","key":"5845_CR55","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004827","volume":"95","author":"L Cavagna","year":"2016","unstructured":"Cavagna L, Codullo V, Ghio S, Scir\u00e8 CA, Guzzafame E, Scelsi L, Rossi S, Montecucco C, Caporali R (2016) Undiagnosed connective tissue diseases: high prevalence in pulmonary arterial hypertension patients. Medicine (Baltimore) 95(39):e4827","journal-title":"Medicine (Baltimore)"},{"key":"5845_CR56","volume":"2014","author":"S Kobak","year":"2014","unstructured":"Kobak S, Kalkan S, Kirilmaz B, Orman M, Ercan E (2014) Pulmonary arterial hypertension in patients with primary Sj\u00f6gren\u2019s syndrome. Autoimmune Dis 2014:710401","journal-title":"Autoimmune Dis"},{"issue":"1","key":"5845_CR57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12890-019-0983-7","volume":"19","author":"J Yang","year":"2019","unstructured":"Yang J, Peng M, Shi J, Zhong W, Yu X (2019) Pulmonary artery involvement in Takayasu\u2019s arteritis: diagnosis before pulmonary hypertension. BMC Pulm Med 19(1):225","journal-title":"BMC Pulm Med"},{"key":"5845_CR58","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ijcard.2018.10.074","volume":"276","author":"H Direskeneli","year":"2019","unstructured":"Direskeneli H (2019) Pulmonary hypertension in Takayasu\u2019s arteritis: should be monitored closely. Int J Cardiol 276:238\u2013239","journal-title":"Int J Cardiol"},{"key":"5845_CR59","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ijcard.2018.08.047","volume":"276","author":"J Gong","year":"2019","unstructured":"Gong J, Yang Y, Ma Z, Guo X, Wang J, Kuang T, Yang S, Li J, Miao R, Huang K (2019) Clinical and imaging manifestations of Takayasu\u2019s arteritis with pulmonary hypertension: a retrospective cohort study in China. Int J Cardiol 276:224\u2013229","journal-title":"Int J Cardiol"},{"issue":"1","key":"5845_CR60","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13075-021-02675-9","volume":"23","author":"H Mukoyama","year":"2021","unstructured":"Mukoyama H, Shirakashi M, Tanaka N, Iwasaki T, Nakajima T, Onizawa H, Tsuji H, Kitagori K, Akizuki S, Nakashima R, Murakami K, Tanaka M, Morinobu A, Yoshifuji H (2021) The clinical features of pulmonary artery involvement in Takayasu arteritis and its relationship with ischemic heart diseases and infection. Arthritis Res Ther 23(1):293","journal-title":"Arthritis Res Ther"},{"issue":"50","key":"5845_CR61","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036563","volume":"102","author":"E Berardi","year":"2023","unstructured":"Berardi E, Antonica G, Procaccio A, Marziliano D, Susca N, Leone P, Sabb\u00e0 C, Racanelli V, Prete M (2023) Cutaneous polyarteritis nodosa and pulmonary arterial hypertension: an unexpected liaison\u2014a case report. Medicine (Baltimore) 102(50):e36563","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"5845_CR62","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.rmed.2011.07.022","volume":"105","author":"E Seyahi","year":"2011","unstructured":"Seyahi E, Baskurt M, Melikoglu M, Akman C, Olgun DC, Simsek E, Hamuryudan V, Kucukoglu S, Yazici H (2011) The estimated pulmonary artery pressure can be elevated in Beh\u00e7et\u2019s syndrome. Respir Med 105(11):1739\u20131747","journal-title":"Respir Med"},{"issue":"2","key":"5845_CR63","doi-asserted-by":"publisher","first-page":"W158","DOI":"10.2214\/AJR.09.2763","volume":"194","author":"N Ceylan","year":"2010","unstructured":"Ceylan N, Bayraktaroglu S, Erturk SM, Savas R, Alper H (2010) Pulmonary and vascular manifestations of Behcet disease: imaging findings. AJR Am J Roentgenol 194(2):W158\u2013W164","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"5845_CR64","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.amjmed.2004.05.027","volume":"117","author":"V Hamuryudan","year":"2004","unstructured":"Hamuryudan V, Er T, Seyahi E, Akman C, T\u00fcz\u00fcn H, Fresko I, Yurdakul S, Numan F, Yazici H (2004) Pulmonary artery aneurysms in Beh\u00e7et syndrome. Am J Med 117(11):867\u2013870","journal-title":"Am J Med"},{"issue":"2","key":"5845_CR65","doi-asserted-by":"publisher","first-page":"563","DOI":"10.55730\/1300-0144.5617","volume":"53","author":"B Arma\u011fan","year":"2023","unstructured":"Arma\u011fan B, Ok\u015ful M, \u015eener YZ, Sar\u0131 A, Erden A, Yard\u0131mc\u0131 GK, Hayran KM, K\u0131l\u0131\u00e7 L, Karada\u011f \u00d6, Kaya EB, Tokg\u00f6zo\u011flu SL, Ertenli A\u0130 (2023) Pulmonary hypertension in Beh\u00e7et\u2019s disease: echocardiographic screening and multidisciplinary approach. Turk J Med Sci 53(2):563\u2013571","journal-title":"Turk J Med Sci"},{"issue":"5","key":"5845_CR66","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1365-4632.2010.04424.x","volume":"49","author":"G Heper","year":"2010","unstructured":"Heper G, Polat M, Yetkin E, Senen K (2010) Cardiac findings in Beh\u00e7et\u2019s patients. Int J Dermatol 49(5):574\u2013578","journal-title":"Int J Dermatol"},{"issue":"60","key":"5845_CR67","first-page":"S79","volume":"28","author":"G Espinosa","year":"2010","unstructured":"Espinosa G, Blanco I, Ant\u00f3n JM, S\u00e1nchez M, Macchiarini P, Barber\u00e0 JA (2010) Chronic thromboembolic pulmonary hypertension in Beh\u00e7et\u2019s disease: effectiveness of endarterectomy. Clin Exp Rheumatol 28(60):S79-81","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"5845_CR68","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.hfc.2018.02.009","volume":"14","author":"CJ Mullin","year":"2018","unstructured":"Mullin CJ, Klinger JR (2018) Chronic thromboembolic pulmonary hypertension. Heart Fail Clin 14(3):339\u2013351","journal-title":"Heart Fail Clin"},{"issue":"4","key":"5845_CR69","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMra0910203","volume":"364","author":"G Piazza","year":"2011","unstructured":"Piazza G, Goldhaber SZ (2011) Chronic thromboembolic pulmonary hypertension. N Engl J Med 364(4):351\u2013360","journal-title":"N Engl J Med"},{"issue":"3","key":"5845_CR70","first-page":"223","volume":"23","author":"D Launay","year":"2006","unstructured":"Launay D, Souza R, Guillevin L, Hachulla E, Pouchot J, Simonneau G, Humbert M (2006) Pulmonary arterial hypertension in ANCA-associated vasculitis. Sarcoidosis Vasc Diffuse Lung Dis 23(3):223\u2013228","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"9","key":"5845_CR71","first-page":"16850","volume":"8","author":"Y Li","year":"2015","unstructured":"Li Y, Yi Q (2015) Pulmonary arterial hypertension associated with rare cause of ANCA-associated vasculitis misdiagnosed as idiopathic one. Int J Clin Exp Med 8(9):16850\u201316853","journal-title":"Int J Clin Exp Med"},{"issue":"12","key":"5845_CR72","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1007\/s10067-017-3868-2","volume":"36","author":"SS Ahn","year":"2017","unstructured":"Ahn SS, Park ES, Jung SM, Song JJ, Park YB, Lee SW (2017) Echocardiographic features in patients with ANCA-associated vasculitis within 3 months before and after diagnosis. Clin Rheumatol 36(12):2751\u20132759","journal-title":"Clin Rheumatol"},{"issue":"7\u20138","key":"5845_CR73","first-page":"16758","volume":"134","author":"M Jermakow","year":"2024","unstructured":"Jermakow M, Danielewicz K, Dudzi\u0144ska K, Bienias P, Roik M, Pruszczyk P (2024) Transient severe precapillary pulmonary hypertension caused by eosinophilic granulomatosis with polyangiitis in a patient with asthma. Pol Arch Intern Med 134(7\u20138):16758","journal-title":"Pol Arch Intern Med"},{"issue":"2","key":"5845_CR74","volume":"40","author":"M Baqir","year":"2023","unstructured":"Baqir M, Singam NS, DuBrock H (2023) Pulmonary hypertension in ANCA-associated vasculitis: a retrospective analysis. Sarcoidosis Vasc Diffuse Lung Dis 40(2):e2023020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"42","key":"5845_CR75","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1093\/eurheartj\/ehab599","volume":"42","author":"X Jiang","year":"2021","unstructured":"Jiang X, Zhu Y-J, Zhou Y-P (2021) Clinical features and survival in Takayasu\u2019s arteritis-associated pulmonary hypertension: a nationwide study. Eur Heart J 42(42):4298\u20134305","journal-title":"Eur Heart J"},{"issue":"42","key":"5845_CR76","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1093\/eurheartj\/ehab688","volume":"42","author":"Y Fukumoto","year":"2021","unstructured":"Fukumoto Y (2021) Takayasu arteritis-associated pulmonary hypertension. Eur Heart J 42(42):4306\u20134308","journal-title":"Eur Heart J"},{"key":"5845_CR77","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41569-019-0176-3","volume":"16","author":"N Dhaun","year":"2019","unstructured":"Dhaun N, Webb DJ (2019) Endothelins in cardiovascular biology and therapeutics. Nat Rev Cardiol 16:491\u2013502","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"5845_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160108","volume":"11","author":"CA Fiddler","year":"2016","unstructured":"Fiddler CA, Parfrey H, Cowburn AS, Luo D, Nash GB, Murphy G, Chilvers ER (2016) The Aminopeptidase CD13 induces homotypic aggregation in neutrophils and impairs collagen invasion. PLoS ONE 11(7):e0160108. https:\/\/doi.org\/10.1371\/journal.pone.0160108. (PMID: 27467268; PMCID: PMC4965216)","journal-title":"PLoS ONE"},{"issue":"11","key":"5845_CR79","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/JIR.S174326","volume":"29","author":"I Floris","year":"2018","unstructured":"Floris I, Appel K, Rose T, Lejeune B (2018) 2LARTH\u00ae, a micro-immunotherapy medicine, exerts anti-inflammatory effects in vitro and reduces TNF-\u03b1 and IL-1\u03b2 secretion. J Inflamm Res 29(11):397\u2013405. https:\/\/doi.org\/10.2147\/JIR.S174326. (PMID: 30464572; PMCID: PMC6211308)","journal-title":"J Inflamm Res"},{"key":"5845_CR80","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1742-2094-10-51","volume":"10","author":"Y Koyama","year":"2013","unstructured":"Koyama Y, Kotani M, Sawamura T, Kuribayashi M, Konishi R, Michinaga S (2013) Different actions of endothelin-1 on chemokine production in rat cultured astrocytes: reduction of CX3CL1\/fractalkine an increase in, C.C.L.2.\/.M.C.P.-1.; CXCL1\/CINC-1. J Neuroinflamm 10:51","journal-title":"J Neuroinflamm"},{"issue":"2","key":"5845_CR81","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5339\/gcsp.2014.29","volume":"2014","author":"AH Chester","year":"2014","unstructured":"Chester AH, Yacoub MH (2014) The role of endothelin-1 in pulmonary arterial hypertension. Glob Cardiol Sci Pract 2014(2):62\u201378. https:\/\/doi.org\/10.5339\/gcsp.2014.29","journal-title":"Glob Cardiol Sci Pract"},{"issue":"10","key":"5845_CR82","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1161\/ATVBAHA.116.307634","volume":"36","author":"L Aldabbous","year":"2016","unstructured":"Aldabbous L, Abdul-Salam V, McKinnon T, Duluc L, Pepke-Zaba J, Southwood M, Ainscough AJ, Hadinnapola C, Wilkins MR, Toshner M, Wojciak-Stothard B (2016) Neutrophil extracellular traps promote angiogenesis: evidence from vascular pathology in pulmonary hypertension. Arterioscler Thromb Vasc Biol 36(10):2078\u20132087","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"5845_CR83","doi-asserted-by":"publisher","first-page":"R473","DOI":"10.1152\/ajpregu.00355.2012","volume":"304","author":"D Salvemini","year":"2013","unstructured":"Salvemini D, Kim SF, Mollace V (2013) Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications. Am J Physiol Regul Integr Comp Physiol 304(7):R473\u2013R487. https:\/\/doi.org\/10.1152\/ajpregu.00355.2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"5845_CR84","doi-asserted-by":"publisher","first-page":"C254","DOI":"10.1152\/ajpcell.00315.2016","volume":"312","author":"K Ghimire","year":"2017","unstructured":"Ghimire K, Altmann HM, Straub AC, Isenberg JS (2017) Nitric oxide: what\u2019s new to NO? Am J Physiol Cell Physiol 312:C254\u2013C262","journal-title":"Am J Physiol Cell Physiol"},{"key":"5845_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apha.2016.05.001","volume":"77","author":"FZ M\u00f3nica","year":"2016","unstructured":"M\u00f3nica FZ, Bian K, Murad F (2016) The endothelium-dependent nitric oxide-cGMP pathway. Adv Pharmacol 77:1\u201327","journal-title":"Adv Pharmacol"},{"issue":"9","key":"5845_CR86","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00424-021-02556-9","volume":"473","author":"S Das","year":"2021","unstructured":"Das S, Chen Y, Yan J, Christensen G, Belhadj S, Tolone A, Paquet-Durand F (2021) The role of cGMP-signalling and calcium-signalling in photoreceptor cell death: perspectives for therapy development. Pflugers Arch 473(9):1411\u20131421","journal-title":"Pflugers Arch"},{"issue":"2","key":"5845_CR87","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00210-019-01779-z","volume":"393","author":"A Friebe","year":"2020","unstructured":"Friebe A, Sandner P, Schmidtko A (2020) cGMP: a unique 2nd messenger molecule - recent developments in cGMP research and development. Naunyn Schmiedebergs Arch Pharmacol 393(2):287\u2013302","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"42","key":"5845_CR88","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.2174\/0929867327666200522215047","volume":"27","author":"Z L\u00e1z\u00e1r","year":"2020","unstructured":"L\u00e1z\u00e1r Z, M\u00e9sz\u00e1ros M, Bikov A (2020) The nitric oxide pathway in pulmonary arterial hypertension: pathomechanism, biomarkers and drug targets. Curr Med Chem 27(42):7168\u20137188","journal-title":"Curr Med Chem"},{"issue":"Suppl S100","key":"5845_CR89","first-page":"129","volume":"34","author":"J Roddy","year":"2016","unstructured":"Roddy J, Lester S, Rischmueller M, Zochling J et al (2016) The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study. Clin Exp Rheumatol 34(Suppl S100):129\u2013136","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"5845_CR90","first-page":"382","volume":"2014","author":"JA Mitchell","year":"2014","unstructured":"Mitchell JA, Ahmetaj-Shala B, Kirkby NS, Wright WR, Mackenzie LS, Reed DM, Mohamed N (2014) Role of prostacyclin in pulmonary hypertension. Glob Cardiol Sci Pract 2014(4):382\u2013393","journal-title":"Glob Cardiol Sci Pract"},{"key":"5845_CR91","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.matbio.2016.01.012","volume":"51","author":"SA Jimenez","year":"2016","unstructured":"Jimenez SA, Piera-Velazquez S (2016) Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of systemic sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension: myth or reality? Matrix Biol 51:26\u201336","journal-title":"Matrix Biol"},{"key":"5845_CR92","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.ajpath.2015.03.019","volume":"185","author":"RB Good","year":"2015","unstructured":"Good RB, Gilbane AJ, Trinder SL, Denton CP, Coghlan G, Abraham DJ, Holmes AM (2015) Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary artery hypertension. Am J Pathol 185:1850\u20131858","journal-title":"Am J Pathol"},{"key":"5845_CR93","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2466-9-18","volume":"9","author":"AI Papaioannou","year":"2009","unstructured":"Papaioannou AI, Zakynthinos E, Kostikas K, Kiropoulos T, Koutsokera A, Ziogas A, Koutroumpas A, Sakkas L, Gourgoulianis KI, Daniil ZD (2009) Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis. BMC Pulm Med 9:18","journal-title":"BMC Pulm Med"},{"key":"5845_CR94","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1253\/circrep.CR-20-0096","volume":"3","author":"S Adachi","year":"2021","unstructured":"Adachi S, Kikuchi R, Shimokata S, Suzuki A, Yoshida M, Imai R, Nakano Y, Kondo T, Murohara T (2021) Endostatin and vascular endothelial growth factor-A165b may contribute to classification of pulmonary hypertension. Circ Rep 3:161\u2013169","journal-title":"Circ Rep"},{"key":"5845_CR95","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13075-015-0756-5","volume":"17","author":"S Reiseter","year":"2015","unstructured":"Reiseter S, Molberg O, Gunnarsson R, Lund MB, Aalokken TM, Aukrust P, Ueland T, Garen T, Brunborg C, Michelsen A et al (2015) Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: An observational study. Arthritis Res Ther 17:231","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"5845_CR96","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/biomedicines12010046","volume":"12","author":"H Ghani","year":"2023","unstructured":"Ghani H, Pepke-Zaba J (2023) Chronic thromboembolic pulmonary hypertension: a review of the multifaceted pathobiology. Biomedicines 12(1):46","journal-title":"Biomedicines"},{"key":"5845_CR97","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/rheumatology\/kes068","volume":"51","author":"T Barnes","year":"2012","unstructured":"Barnes T, Giddon A, Dor\u00e9 CJ, Maddison P, Moots RJ (2012) The QUINs trial study group baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis. Rheumatology 51:1606\u20131609","journal-title":"Rheumatology"},{"issue":"1","key":"5845_CR98","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000490201","volume":"140","author":"M Demeulenaere","year":"2018","unstructured":"Demeulenaere M, Devreese K, Vanbelleghem H, De Zaeytijd J, Vande Walle J, Van Biesen W, Van Laecke S (2018) Thrombomodulin and endothelial dysfunction: a disease-modifier shared between malignant hypertension and atypical hemolytic uremic syndrome. Nephron 140(1):63\u201373","journal-title":"Nephron"},{"key":"5845_CR99","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2332\/allergolint.11-RAI-0337","volume":"60","author":"N Sasaki","year":"2011","unstructured":"Sasaki N, Kamataki A, Sawai T (2011) A histopathological study of pulmonary hypertension in connective tissue disease. Allergol Int 60:411\u2013417","journal-title":"Allergol Int"},{"key":"5845_CR100","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/978-3-030-63046-1_19","volume":"1303","author":"T Klouda","year":"2021","unstructured":"Klouda T, Yuan K (2021) Inflammation in pulmonary arterial hypertension. Adv Exp Med Biol 1303:351\u2013372","journal-title":"Adv Exp Med Biol"},{"key":"5845_CR101","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L Van Bon","year":"2014","unstructured":"Van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, Farina GA, Stifano G, Mather AL, Cossu M et al (2014) Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Eng J Med 370:433\u2013443","journal-title":"N Eng J Med"},{"key":"5845_CR102","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1186\/ar3242","volume":"13","author":"BJ Rabquer","year":"2011","unstructured":"Rabquer BJ, Tsou PS, Hou Y, Thirunavukkarasu E, Haines GK III, Impens AJ, Phillips K, Kahaleh B, Seibold JR, Koch AE (2011) Dysregulated expression of MIG\/CXCL9, IP-10\/CXCL10 and CXCL16 and their receptors in systemic sclerosis. Arthritis Res Ther 13:R18","journal-title":"Arthritis Res Ther"},{"key":"5845_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012106","volume":"5","author":"SA Pendergrass","year":"2010","unstructured":"Pendergrass SA, Hayes E, Farina G, Lemaire R, Farber HW, Whitfield ML, Lafyatis R (2010) Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoS ONE 5:e12106","journal-title":"PLoS ONE"},{"key":"5845_CR104","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/art.30318","volume":"63","author":"RB Christmann","year":"2011","unstructured":"Christmann RB, Hayes E, Pendergrass S, Padilla C, Farina G, Affandi AJ, Whitfield ML, Farber HW, Lafyatis R (2011) Interferon and alternative activation of monocyte\/macrophages in systemic sclerosis-associated pulmonary arterial hypertension. Arthritis Rheum 63:1718\u20131728","journal-title":"Arthritis Rheum"},{"key":"5845_CR105","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1378\/chest.10-2015","volume":"139","author":"A Sachdev","year":"2011","unstructured":"Sachdev A, Villarraga HR, Frantz RP et al (2011) Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. Chest 139:1299\u20131309","journal-title":"Chest"},{"key":"5845_CR106","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","volume":"122","author":"M Humbert","year":"2010","unstructured":"Humbert M, Sitbon O, Chaouat A et al (2010) Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122:156\u2013163","journal-title":"Circulation"},{"key":"5845_CR107","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","volume":"17","author":"JP Goetze","year":"2020","unstructured":"Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ (2020) Cardiac natriuretic peptides. Nat Rev Cardiol 17:698\u2013717. https:\/\/doi.org\/10.1038\/s41569-020-0381-0","journal-title":"Nat Rev Cardiol"},{"key":"5845_CR108","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.3390\/ijms20092281","volume":"20","author":"AJ Moyes","year":"2019","unstructured":"Moyes AJ, Hobbs AJ (2019) C-type natriuretic peptide: a multifaceted paracrine regulator in the heart and vasculature. Int J Mol Sci 20:2281. https:\/\/doi.org\/10.3390\/ijms20092281","journal-title":"Int J Mol Sci"},{"key":"5845_CR109","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1210\/en.2004-0698","volume":"145","author":"M Bensimon","year":"2004","unstructured":"Bensimon M, Chang AI, de Bold MLK, Ponce A, Carreras D, De Bold AJ (2004) Participation of G proteins in natriuretic peptide hormone secretion from heart atria. Endocrinology 145:5313\u20135321. https:\/\/doi.org\/10.1210\/en.2004-0698","journal-title":"Endocrinology"},{"key":"5845_CR110","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/CIRCHEARTFAILURE.114.001174","volume":"8","author":"BK Huntley","year":"2015","unstructured":"Huntley BK, Sandberg SM, Heublein DM, Sangaralingham SJ, Burnett JCJ, Ichiki T (2015) Pro-B-type natriuretic peptide-1-108 processing and degradation in human heart failure. Circ Heart Fail 8:89\u201397. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001174","journal-title":"Circ Heart Fail"},{"key":"5845_CR111","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DEJ, Drazner MH et al (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. J Am Coll Cardiol 62:e147-239. https:\/\/doi.org\/10.1016\/j.jacc.2013.05.019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"5845_CR112","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fphys.2018.00609","volume":"23","author":"A Sydykov","year":"2018","unstructured":"Sydykov A, Mamazhakypov A, Petrovic A, Kosanovic D, Sarybaev AS, Weissmann N, Ghofrani HA, Schermuly RT (2018) Inflammatory mediators drive adverse right ventricular remodeling and dysfunction and serve as potential biomarkers. Front Physiol 23(9):609","journal-title":"Front Physiol"},{"key":"5845_CR113","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12876","author":"M Kato","year":"2018","unstructured":"Kato M, Atsumi T (2018) Pulmonary arterial hypertension associated with connective tissue diseases: a review focusing on distinctive clinical aspects. Eur J Clin Invest. https:\/\/doi.org\/10.1111\/eci.12876","journal-title":"Eur J Clin Invest"},{"key":"5845_CR114","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/604615","volume":"2010","author":"MJ Overbeek","year":"2010","unstructured":"Overbeek MJ, Mouchaers KT, Niessen HM, Hadi AM, Kupreishvili K, Boonstra A, Voskuyl AE, Belien JA, Smit EF, Dijkmans BC, Vonk-Noordegraaf A, Gr\u00fcnberg K (2010) Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension. Int J Rheumatol 2010:604615. https:\/\/doi.org\/10.1155\/2010\/604615","journal-title":"Int J Rheumatol"},{"issue":"1","key":"5845_CR115","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12890-019-0827-5","volume":"19","author":"I Armstrong","year":"2019","unstructured":"Armstrong I, Billings C, Kiely DG et al (2019) The patient experience of pul-monary hypertension: a large cross-sectional study of UK patients. BMC Pulm Med 19(1):67","journal-title":"BMC Pulm Med"},{"issue":"Suppl K","key":"5845_CR116","doi-asserted-by":"publisher","first-page":"K9","DOI":"10.1093\/eurheartj\/suz204","volume":"21","author":"DG Kiely","year":"2019","unstructured":"Kiely DG, Lawrie A, Humbert M (2019) Screening strategies for pulmonary arterial hypertension. Eur Heart J Suppl 21(Suppl K):K9\u2013K20","journal-title":"Eur Heart J Suppl"},{"issue":"153","key":"5845_CR117","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0023-2019","volume":"28","author":"J Weatherald","year":"2019","unstructured":"Weatherald J, Montani D, Jevnikar M et al (2019) Screening for pulmonary arterial hypertension in systemic sclerosis. Eur Respir Rev 28(153):190023","journal-title":"Eur Respir Rev"},{"issue":"1","key":"5845_CR118","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13075-015-0673-7","volume":"17","author":"C Nagel","year":"2015","unstructured":"Nagel C, Henn P, Ehlken N et al (2015) Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension. Arthritis Res Ther 17(1):165","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"5845_CR119","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/rheumatology\/kez473","volume":"59","author":"A Santaniello","year":"2020","unstructured":"Santaniello A, Casella R, Vicenzi M et al (2020) Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 59(7):1581\u20131586","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"5845_CR120","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.semarthrit.2020.02.013","volume":"50","author":"T Semalulu","year":"2020","unstructured":"Semalulu T, Rudski L, Huynh T, Canadian Scleroderma Research Group et al (2020) An evidence-based strategy to screen for pulmonary arterial hypertension in systemic sclerosis. Semin Arthritis Rheum 50(6):1421\u20131427","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"5845_CR121","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s10067-022-06446-y","volume":"42","author":"D\u00dc Cansu","year":"2023","unstructured":"Cansu D\u00dc, Korkmaz C (2023) Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment. Clin Rheumatol 42(10):2601\u20132610","journal-title":"Clin Rheumatol"},{"issue":"7","key":"5845_CR122","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","volume":"73","author":"JG Coghlan","year":"2014","unstructured":"Coghlan JG, Denton CP, Gr\u00fcnig E, DETECT study group et al (2014) Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 73(7):1340\u20131349","journal-title":"Ann Rheum Dis"},{"issue":"38","key":"5845_CR123","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, R\u00e5degran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S (2022) 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43(38):3618\u20133731","journal-title":"Eur Heart J"},{"key":"5845_CR124","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/art.41732","volume":"73","author":"A Young","year":"2021","unstructured":"Young A, Moles VM, Jaafar S, Visovatti S, Huang S, Vummidi D, Nagaraja V, McLaughlin V, Khanna D (2021) Performance of the DETECT algorithm for pulmonary hypertension screening in a systemic sclerosis cohort. Arthritis Rheumatol 73:1731\u20131737","journal-title":"Arthritis Rheumatol"},{"key":"5845_CR125","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","volume":"37","author":"JG Coghlan","year":"2014","unstructured":"Coghlan JG, Denton CP, Gr\u00fcnig E, Bonderman D, Distler O, Khanna D, M\u00fcller-Ladner U, Pope JE, Vonk MC, Doelberg M et al (2014) Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 37:1340\u20131349","journal-title":"Ann Rheum Dis"},{"key":"5845_CR126","doi-asserted-by":"publisher","first-page":"1801904","DOI":"10.1183\/13993003.01904-2018","volume":"53","author":"A Frost","year":"2018","unstructured":"Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A et al (2018) Diagnosis of pulmonary hypertension. Eur Respir J 53:1801904","journal-title":"Eur Respir J"},{"key":"5845_CR127","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.semarthrit.2021.03.011","volume":"51","author":"Z Brown","year":"2021","unstructured":"Brown Z, Proudman S, Morrisroe K, Stevens W, Hansen D, Nikpour M (2021) Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: a systematic review and meta-analysis of long-term outcomes. Semin Arthritis Rheum 51:495\u2013512","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"5845_CR128","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1378\/chest.06-2913","volume":"132","author":"ZC Jing","year":"2007","unstructured":"Jing ZC, Xu XQ, Han ZY et al (2007) Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest 132(2):373\u2013379","journal-title":"Chest"},{"issue":"5","key":"5845_CR129","doi-asserted-by":"publisher","first-page":"H2150","DOI":"10.1152\/ajpheart.01312.2007","volume":"294","author":"IR Henkens","year":"2008","unstructured":"Henkens IR, Mouchaers KTB, Vonk-Noordegraaf A et al (2008) Improved ECG detection of presence and severity of right ventricular pressure load validated with cardiac magnetic resonance imaging. Am J Physiol Heart Circ Physiol 294(5):H2150\u2013H2157","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"5845_CR130","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/1817-1737.203742","volume":"12","author":"M Ascha","year":"2017","unstructured":"Ascha M, Renapurkar RD, Tonelli AR (2017) A review of imaging modalities in pulmonary hypertension. Ann Thorac Med 12(2):61\u201373","journal-title":"Ann Thorac Med"},{"issue":"10","key":"5845_CR131","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/heartjnl-2016-309981","volume":"103","author":"D Dumitrescu","year":"2017","unstructured":"Dumitrescu D, Nagel C, Kovacs G et al (2017) Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis. Heart 103(10):774\u2013782","journal-title":"Heart"},{"issue":"12","key":"5845_CR132","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1164\/rccm.202109-2153ED","volume":"204","author":"MH Lee","year":"2021","unstructured":"Lee MH, Graham BB, Bull TM (2021) Double trouble: airflow and pulmonary vascular obstruction. Am J Respir Crit Care Med 204(12):1365\u20131367","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"5845_CR133","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1183\/09031936.00184412","volume":"42","author":"P Trip","year":"2013","unstructured":"Trip P, Nossent EJ, de Man FS et al (2013) Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. Eur Respir J 42(6):1575\u20131585","journal-title":"Eur Respir J"},{"key":"5845_CR134","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijcard.2020.06.069","volume":"318","author":"L Harbaum","year":"2020","unstructured":"Harbaum L, Fuge J, Kamp JC et al (2020) Blood carbon dioxide tension and risk in pulmonary arterial hypertension. Int J Cardiol 318:131\u2013137","journal-title":"Int J Cardiol"},{"issue":"2","key":"5845_CR135","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.pcad.2012.07.003","volume":"55","author":"AB Waxman","year":"2012","unstructured":"Waxman AB (2012) Exercise physiology and pulmonary arterial hypertension. Prog Cardiovasc Dis 55(2):172\u2013179. https:\/\/doi.org\/10.1016\/j.pcad.2012.07.003. (PMID: 23009913)","journal-title":"Prog Cardiovasc Dis"},{"issue":"7","key":"5845_CR136","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23(7):685\u2013713","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"5845_CR137","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.hfc.2018.03.011","volume":"14","author":"M D\u2019Alto","year":"2018","unstructured":"D\u2019Alto M, Dimopoulos K, Coghlan JG et al (2018) Right heart catheterization for the diagnosis of pulmonary hypertension: controversies and practical issues. Heart Fail Clin 14(3):467\u2013477","journal-title":"Heart Fail Clin"},{"issue":"9","key":"5845_CR138","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1007\/s00330-020-06846-1","volume":"30","author":"AJ Swift","year":"2020","unstructured":"Swift AJ, Dwivedi K, Johns C et al (2020) Diagnostic accuracy of CT pulmo-nary angiography in suspected pulmonary hypertension. Eur Radiol 30(9):4918\u20134929","journal-title":"Eur Radiol"},{"issue":"2","key":"5845_CR139","doi-asserted-by":"publisher","first-page":"2202225","DOI":"10.1183\/13993003.02225-2022","volume":"62","author":"S Alabed","year":"2023","unstructured":"Alabed S, Garg P, Alandejani F, Dwivedi K, Maiter A, Karunasaagarar K, Rajaram S, Hill C, Thomas S, Gossling R, Sharkey MJ, Salehi M, Wild JM, Watson L, Hameed A, Charalampopoulos A, Lu H, Rothman AMK, Thompson AAR, Elliot CA, Hamilton N, Johns CS, Armstrong I, Condliffe R, van der Geest RJ, Swift AJ, Kiely DG (2023) Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension. Eur Respir J 62(2):2202225","journal-title":"Eur Respir J"},{"issue":"1","key":"5845_CR140","doi-asserted-by":"publisher","first-page":"1801915","DOI":"10.1183\/13993003.01915-2018","volume":"53","author":"NH Kim","year":"2019","unstructured":"Kim NH, Delcroix M, Jais X et al (2019) Chronic thromboembolic pulmonary hypertension. Eur Respir J 53(1):1801915","journal-title":"Eur Respir J"},{"issue":"12","key":"5845_CR141","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/j.jacc.2006.07.061","volume":"48","author":"MM Hoeper","year":"2006","unstructured":"Hoeper MM, Lee SH, Voswinckel R et al (2006) Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 48(12):2546\u20132552","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"5845_CR142","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jchf.2016.10.012","volume":"5","author":"E Wolsk","year":"2017","unstructured":"Wolsk E, Bakkestr\u00f8m R, Thomsen JH et al (2017) The influence of age on hemodynamic parameters during rest and exercise in healthy indivi-duals. JACC Heart Fail 5(5):337\u2013346","journal-title":"JACC Heart Fail"},{"issue":"3","key":"5845_CR143","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/annrheumdis-2019-216476","volume":"79","author":"P Xanthouli","year":"2020","unstructured":"Xanthouli P, Jordan S, Milde N et al (2020) Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension. Ann Rheum Dis 79(3):370\u2013378","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05845-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05845-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05845-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:12:47Z","timestamp":1744715567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05845-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":143,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["5845"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05845-z","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no financial or non-financial interests that could influence the outcomes of this study. There are no competing interests to report. None of the authors has any conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The figures were developed by the authors using BioRender, in conjunction with Microsoft Word for illustration editing. The tables were prepared using Microsoft Word, which provided key tools for design and formatting.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Software tools and image creation"}}],"article-number":"87"}}